BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29679991)

  • 21. Similar profiles of cognitive domain deficits between medication-naïve patients with bipolar II depression and those with major depressive disorder.
    Liu T; Zhong S; Wang B; Liao X; Lai S; Jia Y
    J Affect Disord; 2019 Jan; 243():55-61. PubMed ID: 30227315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive impairment in schizophrenia and depression: A comparison of stability and course.
    Neu P; Gooren T; Niebuhr U; Schlattmann P
    Appl Neuropsychol Adult; 2019; 26(3):215-228. PubMed ID: 29161150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in cognitive impairment between schizophrenia and bipolar disorder: Considering the role of heterogeneity.
    Bora E
    Psychiatry Clin Neurosci; 2016 Oct; 70(10):424-433. PubMed ID: 27233969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subtypes of depression characterized by different cognitive decline and brain activity alterations.
    Yang X; Qi S; Wang M; Calhoun VD; Sui J; Li T; Ma X
    J Psychiatr Res; 2021 Jun; 138():413-419. PubMed ID: 33962128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superior intellectual ability in schizophrenia: neuropsychological characteristics.
    MacCabe JH; Brébion G; Reichenberg A; Ganguly T; McKenna PJ; Murray RM; David AS
    Neuropsychology; 2012 Mar; 26(2):181-90. PubMed ID: 22201301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report.
    Chakrabarty T; Harkness KL; McInerney SJ; Quilty LC; Milev RV; Kennedy SH; Frey BN; MacQueen GM; Müller DJ; Rotzinger S; Uher R; Lam RW
    Psychol Med; 2020 Nov; 50(15):2536-2547. PubMed ID: 31583989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognitive subgroups among newly diagnosed patients with schizophrenia spectrum or bipolar disorders: A hierarchical cluster analysis.
    Miskowiak KW; Kjærstad HL; Lemvigh CK; Ambrosen KS; Thorvald MS; Kessing LV; Glenthoj BY; Ebdrup BH; Fagerlund B
    J Psychiatr Res; 2023 Jul; 163():278-287. PubMed ID: 37244066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-morbid depressive disorder is associated with better neurocognitive performance in first episode schizophrenia spectrum.
    Herniman SE; Cotton SM; Killackey E; Hester R; Allott KA
    J Affect Disord; 2018 Mar; 229():498-505. PubMed ID: 29334645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive heterogeneity in young offspring of patients with bipolar disorder: The effect of putative clinical stages.
    Bora E; Can G; Ildız A; Ulas G; Ongun CH; Inal NE; Ozerdem A
    J Affect Disord; 2019 Oct; 257():130-135. PubMed ID: 31301613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocognitive impairment in deficit and non-deficit schizophrenia: a meta-analysis.
    Bora E; Binnur Akdede B; Alptekin K
    Psychol Med; 2017 Oct; 47(14):2401-2413. PubMed ID: 28468693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary evidence concerning the pattern and magnitude of cognitive dysfunction in major depressive disorder using cogstate measures.
    Davis MT; DellaGioia N; Matuskey D; Harel B; Maruff P; Pietrzak RH; Esterlis I
    J Affect Disord; 2017 Aug; 218():82-85. PubMed ID: 28460315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions.
    McIntyre RS; Cha DS; Soczynska JK; Woldeyohannes HO; Gallaugher LA; Kudlow P; Alsuwaidan M; Baskaran A
    Depress Anxiety; 2013 Jun; 30(6):515-27. PubMed ID: 23468126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating cognitive deficits and symptomatology across pre-morbid adjustment patterns in first-episode psychosis.
    Béchard-Evans L; Iyer S; Lepage M; Joober R; Malla A
    Psychol Med; 2010 May; 40(5):749-59. PubMed ID: 19732482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cluster analysis differentiates high and low community functioning in schizophrenia: Subgroups differ on working memory but not other neurocognitive domains.
    Alden EC; Cobia DJ; Reilly JL; Smith MJ
    Schizophr Res; 2015 Oct; 168(1-2):273-8. PubMed ID: 26215505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial.
    Mallawaarachchi SR; Amminger GP; Farhall J; Bolt LK; Nelson B; Yuen HP; McGorry PD; Markulev C; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2020 Apr; 218():48-54. PubMed ID: 32171637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective.
    Sheffield JM; Karcher NR; Barch DM
    Neuropsychol Rev; 2018 Dec; 28(4):509-533. PubMed ID: 30343458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.